Navigation Links
Kaiser Permanente Study Shows Newer, Stronger Evidence That Caffeine During Pregnancy Increases Miscarriage Risk
Date:1/21/2008

ried. Whereas 264 women (25 percent) reported no consumption of any caffeine containing beverages during pregnancy, 635 women (60 percent) reported 0-200 mg of caffeine intake per day, and 164 women (15 percent) had 200 mg or more of daily caffeine consumption.

Critics had maintained that the association was not so much a high dose of caffeine intake that increased the risk of miscarriage, but that women with a healthy pregnancy are more likely (than those about to miscarry), to reduce their caffeine intake due to nausea, vomiting, and aversion to caffeine, Li said. "Therefore, the critics claimed that the observed association was a result of reduction of caffeine intake by healthy pregnant women," he said.

So what's a fatigued mom-to-be supposed to do for her daily energy jolt?

"If you definitely need caffeine to get you going, try keeping it to one cup or less a day. Avoiding it may be even better. Consider switching to decaffeinated coffee and other decaffeinated beverages during your pregnancy," said Tracy Flanagan, MD, Director of Women's Health, Kaiser Permanente Northern California. "Learn to perk up instead with natural energy boosts like a brisk walk, yoga stretches, snacking on dried fruits and nuts."

Co-authors on the study included Xiaoping Weng, Ph.D. and Roxana Odouli, MSPH, also with the Kaiser Permanente Division of Research. The Study was supported in part by the California Public Health Foundation.

About the Kaiser Permanente Division of Research

The Kaiser Permanente Division of Research conducts, publishes, and disseminates epidemiologic and health services research to improve the health and medical care of Kaiser Permanente members and the society at large. It seeks to understand the determinants of illness and well being and to improve the quality and cost-effectiveness of health care. Currently, the center's 400-plus staff is working on more than 250 epidemiological and health services research project
'/>"/>

SOURCE Kaiser Permanente
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Kaiser Permanente to Host 30th Annual Diversity Conference
2. Kaiser Permanente Colorado Opens Center for Health Dissemination and Implementation Research
3. Center for Molecular Medicine Selected to Provide DNA Analysis for Childrens Oncology Group Leukemia Study
4. Phase I Safety and Tolerability Study With EVT 302 Successfully Completed
5. Study Examines Media Preferences of Life Scientists in Applied Markets
6. Triage study challenges notions of emergency medical response to disaster
7. Federally-Funded Study Shows More Women Can Avoid Hysterectomy for Common Problem
8. Genmab A/S - R1507 Antibody to Enter Phase II Study to Treat Sarcoma
9. Study Reaffirms Superiority of Trofile(TM) Assay
10. Genzyme Study of Myozyme(R) for Late-Onset Pompe Patients Meets Co-Primary Efficacy Endpoints
11. Genmab Announces Details of Planned Ofatumumab Phase II Study in Multiple Sclerosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... Reportlinker.com announces that a new ... catalogue: ,, The Future of ... 2015, Pipeline Analysis and Reimbursement ... ,, Summary ,, The author ... of Orphan Diseases Therapeutics - Market Forecasts ...
(Date:12/15/2009)... and CHARLOTTESVILLE, Va., Dec. 15 ... the University of Virginia (UVa) in Charlottesville, ... a strategic research collaboration to enhance development ... disease (CAD) with a secondary focus on ... http://www.newscom.com/cgi-bin/prnh/20091027/PH99766LOGO ) ,, The collaborative preclinical ...
(Date:12/15/2009)... --The Mosaic Company (NYSE: MOS ) plans ... results and financial tables on Tuesday, January 5, 2010, ... Stock Exchange. Results will be available on Mosaic,s ... host a conference call with presentation slides on Wednesday, ... call will begin at 11:00 a.m. Eastern Standard Time ...
(Date:12/15/2009)... PHILADELPHIA, Dec. 15 The Center ... Advanstar Communications, is pleased to announce the ... Pharmaceutical/Biotech Accounting and Reporting Congress . The ... Philadelphia, on March 16-17, 2010. ,, Over ... professionals have attended this premier event since ...
Breaking Biology Technology:Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 2Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 3Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 4Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 5Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 6Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 7Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 8Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 9Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 10Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 11Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 12Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 13Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 14Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 15Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 16Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 17Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 18AstraZeneca and the University of Virginia Sign Strategic Research Collaboration to Develop Novel Treatments for Cardiovascular Disease 2AstraZeneca and the University of Virginia Sign Strategic Research Collaboration to Develop Novel Treatments for Cardiovascular Disease 3Mosaic Announces Second Quarter Fiscal Year 2010 Earnings Release and Conference Call 2CBI Announces the Agenda for Their 6th Annual Pharmaceutical/Biotech Accounting and Reporting Congress 2
... China, Sept. 5 /Xinhua-PRNewswire-FirstCall/ -- Huifeng Bio-,Pharmaceutical Technology, ... developer and producer of plant extracts and pharmaceutical ... production in,Xi,an, China, is pleased to announce a ... with Xi,an Qinba Xintong Medical Ltd. ("Qinba").,Under the ...
... MATEO, Calif., Sept. 4 BioForm Medical,Inc. (Nasdaq: BFRM ... full fiscal year ended June 30, 2008. Net sales were ... to $15.4 million,for the quarter ended June 30, 2007, an ... million for the quarter ended June 30, 2008 as,compared to ...
... COLUMBUS, Ohio, Sept. 4 The Ohio State ... country to discuss,translating scientific breakthroughs in the laboratory ... Health Care Conference on,Oct. 16-17., Health care ... experts, academic leaders, and consumer and patient,advocacy groups ...
Other Biology Technology:Huifeng Bio-Pharmaceutical (HFGB) Enters into Letter of Intent with Xi'an Qinba Xintong Medical Ltd. 2BioForm Reports Financial Results for the Fourth Quarter and Full Fiscal Year Ended June 30, 2008 2BioForm Reports Financial Results for the Fourth Quarter and Full Fiscal Year Ended June 30, 2008 3BioForm Reports Financial Results for the Fourth Quarter and Full Fiscal Year Ended June 30, 2008 4BioForm Reports Financial Results for the Fourth Quarter and Full Fiscal Year Ended June 30, 2008 5BioForm Reports Financial Results for the Fourth Quarter and Full Fiscal Year Ended June 30, 2008 6BioForm Reports Financial Results for the Fourth Quarter and Full Fiscal Year Ended June 30, 2008 7BioForm Reports Financial Results for the Fourth Quarter and Full Fiscal Year Ended June 30, 2008 8BioForm Reports Financial Results for the Fourth Quarter and Full Fiscal Year Ended June 30, 2008 9OSU to Host National Personalized Health Care Conference 2
(Date:12/14/2009)... founded a new journal Cardiovascular Engineering and Technology ... a forum for research on all aspects of cardiovascular ... the new quarterly journal will appear in March 2010 ... Annals of Biomedical Engineering and Cellular and ... will present a wide spectrum of research, from ...
(Date:12/14/2009)... are spending the holidays with big Uncle Frank or ... better off with another family, spare a thought for ... from McMaster University and the University of New South ... lives in groups, members make strategic decisions about their ... current issue of Biology Letters . , The ...
(Date:12/14/2009)... thought of tool use as a defining feature of humans. ... primates, along with birds and an array of other mammals. ... Current Biology , a Cell Press publication, adds an octopus ... octopus under study manages a behavioral trick that the researchers ... over stacked, upright coconut shell "bowls," makes its eight arms ...
Breaking Biology News(10 mins):Biomedical Engineering Society's new journal to be published by Springer 2Tool use in an invertebrate: The coconut-carrying octopus 2American Cancer Society Hope Lodges Sign 29th Contract to Implement SoftBrands Systems 53503 1American Cancer Society Hope Lodges Sign 29th Contract to Implement SoftBrands Systems 53503 2Human Genome Sciences Announces Closing of Public Offering 13334 1Human Genome Sciences Announces Closing of Public Offering 13334 2Human Genome Sciences Announces Closing of Public Offering 13334 3National Institutes of Health Chooses Web of Science 28R 29 to Power electronic Scientific Portfolio Assistant 28eSPA 29 13333 1National Institutes of Health Chooses Web of Science 28R 29 to Power electronic Scientific Portfolio Assistant 28eSPA 29 13333 2
... Bulletin Board: BKYI) today announced plans to release first quarter,2008 ... opens.,In conjunction with the release, BIO-key has scheduled a conference ... May 15, 2008 at,9:00 a.m. Eastern Time., What: ... Call ...
... What if hydrology is more important for predicting biodiversity ... the journal Nature challenges current thinking about biodiversity and ... or human activity may affect biodiversity patterns. , ... that the biodiversity of fish species in a river ...
... of the genome sequence of the duck-billed platypus was ... clues about how genomes were organized during the early ... by the National Human Genome Research Institute (NHGRI), part ... of TV nature shows will remember that the duck-billed ...
Other Biology News:BIO-key(R) Announces First Quarter 2008 Earnings Release and Conference Call Schedule 2Biodiversity -- it's in the water 2Duck-billed platypus genome sequence published 2Duck-billed platypus genome sequence published 3Duck-billed platypus genome sequence published 4
Coating : Poly-D-Lysine ,Surface : ECM/attachment factors ,Surface area : 9.6 cm2 ,Dim nominal : 35 mm x 10 mm ,Vol working : 2.5-3.0 ml ...
Rabbit polyclonal to Synapsin II ( Abpromise for all tested applications). entrezGeneID: 6854 SwissProtID: Q92777...
... These primers are designed for sequencing ... the SP6, T7, or T3 RNA polymerase ... They are supplied at a concentration of ... functionally tested in DNA sequencing reactions using ...
... powerful application for DNA and protein ... Expression makes complex computational analyses of ... the very latest computing technology to ... sequences are analysed. Features include: Sequence ...
Biology Products: